PRANDIN

This brand name is authorized in Austria, Estonia, Spain, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom, United States

Active ingredients

The drug PRANDIN contains one active pharmaceutical ingredient (API):

1 Repaglinide UNII 668Z8C33LU - REPAGLINIDE

Repaglinide is a short-acting oral secretagogue. Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β-cells in the pancreatic islets. Read about Repaglinide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRANDIN Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BX02	Repaglinide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1197457, 1197468, 1197479, 1197491, 1197503, 1197514, 1197536, 1197547, 1197558, 1304895, 1304907, 1304918
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00162004, 00162010, 00162016
Country: IT	Agenzia del Farmaco	Identifier(s): 035252016, 035252028, 035252030, 035252042, 035252055, 035252067, 035252079, 035252081, 035252093, 035252105, 035252117, 035252129, 035252131, 035252143, 035252156, 035252168, 035252170, 035252182
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030374, 1030375, 1030376, 1030377, 1030378, 1030382, 1030383, 1030384, 1030385, 1030386, 1030387, 1030388, 1030389, 1030390, 1030391
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100313049, 100313204, 100313210
Country: US	FDA, National Drug Code	Identifier(s): 0169-0081, 0169-0082, 0169-0084, 60846-882, 60846-884